Lee Gary K.
SEC CIK 1907345 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | CSO | 16.2K | — | $89.8K | 12 | 2024-02-09 | 2026-08-21 |
Most active insiders at LYEL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ARCH Venture Partners IX Overage, L.P. | 10% | $12.50M | — |
| 2 | BERNS PAUL L | 10% | $12.50M | — |
| 3 | Seely Lynn | Pres, CEO, Dir | — | $353.1K |
| 4 | Bulis Veronica Sanchez | VP, Corp. Ctrl | — | $96.9K |
| 5 | Lee Gary K. | CSO | — | $71.7K |
| 6 | Hill Stephen J. | COO | — | $51.3K |
| 7 | Shook David | Chief Medical Off | — | $31.3K |
| 8 | Innovative Cellular Therapeutics Holdings Ltd | 10% | — | $274.30 |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-25 16:03 | 2026-08-21 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | CSO | S - Sale | $15.54 | -1,457 | 16.2K | -8% | -$22.6K | |
| 2026-08-11 16:20 | 2026-08-10 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | CSO | S - Sale | $14.34 | -131 | 17.7K | -0.7% | -$1,879 | |
| 2026-06-15 18:35 | 2026-05-11 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | CSO | S - Sale | $18.92 | -130 | 17.8K | -0.7% | -$2,460 | |
| 2026-02-12 | 2026-02-11 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | CSO | S - Sale | $23.39 | -1,671 | 16.9K | -9% | -$39.1K | |
| D | 2026-02-11 | 2026-02-09 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | CSO | A - Grant | $0.00 | +4,000 | 18.8K | +27% | $0 |
| D | 2026-02-11 | 2026-02-10 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | CSO | S - Sale | $23.12 | -147 | 18.6K | -0.8% | -$3,399 |
| 2025-11-12 | 2025-11-10 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | CSO | S - Sale | $16.16 | -138 | 15.4K | -0.9% | -$2,230 | |
| 2025-08-22 | 2025-08-21 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | CSO | S - Sale | $10.54 | -1,453 | 15.5K | -9% | -$15.3K | |
| 2025-08-22 | 2025-08-20 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | CSO | A - Grant | $0.00 | +8,000 | 17.0K | +89% | $0 | |
| M | 2025-08-13 | 2025-08-11+ | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | CSO | S - Sale | $10.43 | -267 | 9,093 | -3% | -$2,786 |
| D | 2025-02-26 | 2025-02-10 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | CSO | A - Grant | $0.00 | +112.5K | 176.7K | +175% | $0 |
| D | 2024-02-13 | 2024-02-09 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | CSO | A - Grant | $0.00 | +40.0K | 52.7K | +315% | $0 |
Purchase Sale Sale after option exercise All abbreviations